{"id":46769,"date":"2022-08-01T11:01:55","date_gmt":"2022-08-01T09:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/"},"modified":"2022-08-01T11:01:55","modified_gmt":"2022-08-01T09:01:55","slug":"rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/","title":{"rendered":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium"},"content":{"rendered":"
\n

\nRWS\u2019s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials<\/i>\n<\/p>\n

CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute\u2019s Electronic Clinical Outcome Assessment (eCOA) Consortium to help drive the science, best practice and adoption of eCOA within clinical trials.\n<\/p>\n

\nThe eCOA Consortium was established by the Critical Path Institute<\/a> (C-Path) in 2011. Its 19 member firms collaborate to support and conduct novel research, design and deliver educational resources and develop and share best-practice recommendations for the electronic collection of clinical outcome data. An eCOA replaces the traditional paper-based approach to collecting patient results, feedback and experiences in clinical trials and studies.\n<\/p>\n

\n\u201cC-Path is proud and excited to welcome RWS as the newest member of the eCOA Consortium,\u201d said Scottie Kern, Executive Director of the eCOA Consortium, \u201cRWS has a major presence in the eCOA space and is the type of organization that can bring a unique perspective on multilingual eCOA implementation, and, together with other consortium members, will help further drive improvements in this critical step in the clinical trial process.\u201d\n<\/p>\n

\nRWS\u2019s expertise is built on a long history in linguistically validating over 20,000 clinical outcome assessments into 500+ language pairs in over 200 different specific therapeutic and disease areas, including cardiovascular, allergy, respiratory, oncology, gastroenterology, inflammation, neurology, infectious diseases and vaccines.\n<\/p>\n

\n\u201cWe\u2019re always looking for ways to pioneer and shape the future of our industry,\u201d explains Alisa Heinzman, Manager of eCOA Solutions, RWS. \u201cJoining the Consortium demonstrates our commitment to our clients and the industry by helping to drive the science, best practice and adoption of eCOA within clinical assessments.\u201d\n<\/p>\n

\nRWS\u2019s state-of-the-art linguistic validation process and eCOA services<\/a> ensure both the accuracy and timely completion of projects. Global relationships with translators, interviewers, instrument developers, survey research experts, clinicians and in-country reviewers ensure that each linguistic validation project is expedited with ease and scientific accuracy.\n<\/p>\n

\nAbout RWS<\/b>\n<\/p>\n

\nRWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language.\n<\/p>\n

\nOur purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.\n<\/p>\n

\nOur clients include 90 of the world\u2019s top 100 brands, the top 20 pharmaceutical companies and 19 of the top 20 patent filers. Our client base spans Europe, Asia Pacific and North and South America. We work in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors, which we serve from 80+ global locations across five continents.\n<\/p>\n

\nFounded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).\n<\/p>\n

\nFor further information, please visit: www.rws.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nRWS
\n
Denis Davies
\n
Corporate Communications
\n
ddavies@rws.com<\/a><\/span>
+44 1628 410105\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RWS\u2019s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute\u2019s Electronic Clinical Outcome Assessment (eCOA) Consortium to help … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46769","6":"format-standard","7":"category-industry"},"yoast_head":"\nRWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RWS\u2019s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute\u2019s Electronic Clinical Outcome Assessment (eCOA) Consortium to help ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-01T09:01:55+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium\",\"datePublished\":\"2022-08-01T09:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/\"},\"wordCount\":525,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/\",\"name\":\"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-01T09:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/","og_locale":"en_US","og_type":"article","og_title":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend","og_description":"RWS\u2019s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute\u2019s Electronic Clinical Outcome Assessment (eCOA) Consortium to help ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-01T09:01:55+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium","datePublished":"2022-08-01T09:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/"},"wordCount":525,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/","url":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/","name":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-01T09:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rws-joins-the-electronic-clinical-outcome-assessment-ecoa-consortium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46769"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46769\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}